HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Chloroform → (6-Bromopyridin-3-yl)[4-(p-tolyloxy)piperidin-1-yl]methanone
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | Chloroform | HCID 6212 | — |
| Edukt | 6-Bromonicotinic acid | HCID 238932 | — |
| Edukt | 4-(4-Methylphenoxy)piperidine | HCID 3837497 | — |
| Edukt | 4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate | HCID 23149411 | — |
| Lösungsmittel | Methanol | HCID 887 | — |
| Produkt | (6-Bromopyridin-3-yl)[4-(p-tolyloxy)piperidin-1-yl]methanone | HCID 58484591 | 99,9% |
Reaktionsschritte
To a mixture of 4-(p-tolyloxy)piperidine (765 mg), 6-bromonicotinic acid (808 mg) and 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMT-MM) (1.7 g) were added chloroform (5 mL) and methanol (5 mL), and the mixture was stirred at room temperature overnight. After evaporation of the solvent, the residue was purified by column chromatography (chloroform:methanol) to give the title compound (1.5 g).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08354401B2 |
| Quelldatensatz | uspto-grants-2013_01 |
| ORD ID | ord-31d277f31d42413fbaa18166042e1a7d |
| Quellennotiz | uspto-grants-2013_01 |